Developing new methods for creating complex medicines using nickel and light
New Directions in Nickel and Photoredox Catalysis
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-11055399
This study is looking at new ways to make medicines by using nickel and light to create important chemical connections more easily, which could lead to the development of new life-saving drugs for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-11055399 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative chemical reactions that can help in the development of new medicines. By utilizing nickel and light as catalysts, the project aims to improve the way complex chemical structures are synthesized, making the process more efficient and sustainable. The research will explore new principles of catalysis to enhance the formation of carbon bonds, which are crucial for the bioactivity of drug candidates. Patients may benefit from the eventual discovery of new life-saving drugs that arise from these improved synthetic methods.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new drug candidates developed through these innovative synthetic methods.
Not a fit: Patients with conditions that are not addressed by the types of drugs being developed through this research may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective medicines for various diseases.
How similar studies have performed: Previous research has shown success in using similar catalytic approaches to develop new drugs, indicating a promising avenue for future breakthroughs.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DOYLE, ABIGAIL GUTMANN — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: DOYLE, ABIGAIL GUTMANN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.